Amiodarone and Lithium-induced thyroid dysfunction: who initiates the prescribing cascade?
Description
Prescribing cascades occur, when an undetected adverse drug reaction results in the prescription of additional medication, leading to polypharmacy. The involvement of physicians from different specialties in prescribing cascades remains unclear. This study focuses on amiodarone and lithium initiation in hospitals, with subsequent thyroid dysfunction treatment occurring in primary and/or secondary care and whether the specialty of the physician initiating amiodarone or lithium differs from the specialty of the physician initiating the thyroid medication.
Who is the principal investigator?
Dr. Fatma Karapinar-Çarkit
Team
Dr. Judith de Ruijter - van Dalem
Who is collaborating?
M. de Weerd – Slot (OLVG)
M.H. Schipper (OLVG/Spaarne Gasthuis)
C.E.H. Siegert (OLVG)
A. Marmorale (EPIC)
M.L. Becker (Spaarne Gasthuis)
Are we looking for students or researchers to collaborate on this project?
We offer both short-and long-term internships for students interested in areas such as adverse drug reactions, medication safety, and pharmacy in general.
Also, visit our Vacancies page.
Contact for internship or collaboration
Dr. Fatma Karapinar-Çarkit (f.karapinar@mumc.nl)
Contact for general questions
Dr. Judith de Ruijter-van Dalem (judith.van.dalem@mumc.nl)